Tiazofurine
Alternative Names: CI 909; CPD 5825; ICN 5825; NSC 286193; Riboxamide; Tiazofurin; TiazoleLatest Information Update: 19 Jul 2018
At a glance
- Originator Valeant Pharmaceuticals International
- Class Amides; Cytostatics; Ribonucleosides; Small molecules; Thiazoles
- Mechanism of Action Immunomodulators; Inosine monophosphate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Multiple myeloma; Myeloid leukaemia; Ovarian cancer
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 16 Jun 2003 Suspended - Phase-I for Multiple myeloma in Russia (IV)
- 16 Jun 2003 Suspended - Phase-II for Ovarian cancer in Russia (IV)